VivoSeq
Other

Observational Study

0

Pipeline Programs↗

32

Active Trials↗

42

Companies Involved↗

Observational Study is an early-stage landscape with 0 programs across 42 companies. The most active players are Novo Nordisk, Bayer, GSK.

Intelligence

Pipeline Metrics

Competitive Density

42/100

Pipeline Velocity

30/100

Mech. Concentration

N/A

Completion Rate

95/100

Attrition Rate

4/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Novo Nordisk logo

Novo Nordisk

0 programs

PreclinicalBayer logo

Bayer

0 programs

PreclinicalGSK logo

GSK

0 programs

PreclinicalJohnson & Johnson logo

Johnson & Johnson

0 programs

PreclinicalMerck & Co. logo

Merck & Co.

0 programs

PreclinicalAstraZeneca logo

AstraZeneca

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

228

clinical trials

Completed161 · 71%
Unknown status26 · 11%
Recruiting16 · 7%
Terminated8 · 4%
Active, not recruiting7 · 3%
Not yet recruiting5 · 2%
Other5 · 2%

Clinical Trials

Trial Activity

228 trials

A Retrospective Observational Study on the Effects of Probiotics on HBsAg Clearance
Recruiting·QQilu Hospital of Shandong University·N/A·NCT06313255·40 enrolled
Prospective, Long Term, Observational Study (Patient Registry) of Paediatric Myotonic Disorders
Recruiting·LLupin Ltd.·N/A·NCT07154654·10 enrolled
Efficacy and Prognosis of Microwave Ablation Treatment for Papillary Thyroid Microcarcinoma Assessed by Contrast-Enhanced Ultrasound Combined With Genetic and Molecular Diagnostics: A Prospective Observational Study
Recruiting·SSun Yat-Sen Memorial Hospital of Sun Yat-Sen University·N/A·NCT07054229·480 enrolled
Multicenter, Open, Prospective, 48 Weeks, Observational Study ,Evaluate the Safety and Efficacy of Nephoxil Capsule
Recruiting·KKyowa Kirin Korea Co., Ltd.·N/A·NCT06206135·100 enrolled
VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study
Recruiting·AAlimentiv Inc.·N/A·NCT06249555·300 enrolled
Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.
Recruiting·SSpanish Oncology Genito-Urinary Group·N/A·NCT06724159·500 enrolled
Observational Study of Afatinib 30 mg Daily
Recruiting·NNational University Hospital, Singapore·N/A·NCT04909073·69 enrolled
Prospective Evaluation on the Role Exerted by Hormonal Contraceptives on 24-h Blood Pressure. A Prospective Observational Study
Recruiting·OOspedale Policlinico San Martino·N/A·NCT07061093·96 enrolled
ROLL'YN-UST: an Observational Study in Patients Treated by Steqeyma®, an Ustekinumab Biosimilar
Recruiting·CCelltrion HealthCare France·N/A·NCT06997055·225 enrolled
ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar
Recruiting·CCelltrion HealthCare France·N/A·NCT07425639·225 enrolled
Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure
Recruiting·Octapharma logoOctapharma·N/A·NCT06429787·3,574 enrolled
An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions
Recruiting·Bayer logoBayer·N/A·NCT06278207·50,000 enrolled
An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics
Recruiting·RRECORDATI GROUP·N/A·NCT05040178·20 enrolled
A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients
Recruiting·Chiesi Farmaceutici S.p.A. logoChiesi Farmaceutici S.p.A.·N/A·NCT06663358·100 enrolled
CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS)
Recruiting·UUniversity Health Network, Toronto·N/A·NCT04151342·5,500 enrolled
Page 1 of 16

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)